IND Modification for Phase I Clinical Trial
- Area: Greater Seattle Area
- Project Type: Regulatory Affairs, Technical Writing
About this Project
Client received FDA responses to initial Phase I Clinical Trial submission. Client required support in ensuring documents were modified and complete for FDA submission.
PSC® supported a small, start-up biopharmaceutical company with their Investigational New Drug (IND) application. With commentary from the FDA and a short time-line, PSC provided updates and modifications to the IND Phase I Clinical Trial Submission to ensure FDA approval. PSC® also provided Strategies for Optimization of Design of Forms to set the client up for success for future submissions.
PSC® has successfully completed the IND Modification for Phase I Clinical Trial within scope, schedule, and budget, and received outstanding feedback from the client’s Executive Team.
Greater Los Angeles Facility Expansion
Greater Los Angeles Varied Services
Greater Los Angeles Cleaning Validation
How Can We Help You?